Use of proteomics to identify mechanisms of hepatocellular carcinoma with the CYP2D6*10 polymorphism and identification of ANGPTL6 as a new diagnostic and prognostic biomarker

Hu, GM; Gao, F; Wang, GZ; Fang, Y; Guo, YY; Zhou, J; Gu, YH; Zhang, CZ; Gao, N; Wen, Q; Qiao, HL

Qiao, HL (corresponding author), Zhengzhou Univ, Inst Clin Pharmacol, Zhengzhou 450052, Henan, Peoples R China.

JOURNAL OF TRANSLATIONAL MEDICINE, 2021; 19 (1):

Abstract

Background Although an association between the cytochrome P4502D6 (CYP2D6) *10 (100C>T) polymorphism and hepatocellular carcinoma (HCC) is known, t......

Full Text Link